The FinTech Nation
In a world where digital innovation reigns supreme, Singapore’s ascent to FinTech prominence is nothing short of extraordinary. With a reputation for integrity, a conducive business environment, and unwavering support for financial innovation, this...
Graphite Erased: LENZ to Merge with Gene Editing Therapy Developer
By Alex Philippidis
Graphite Bio has agreed to merge into LENZ Therapeutics, creating a combined company focused on advancing LENZ’s lead pipeline candidates, designed to address presbyopia—nearly a year after Graphite began exploring strategic alternatives...
From Flat to Functional: Tools and Techniques for Working with Spheroids and Organoids
REGISTER NOW
Broadcast Date: December 21, 2023Time: 8:00 am PT, 11:00 am ET, 17:00 CET Spheroids and organoids have significant advantages over traditional two-dimensional (2D) cell cultures, in large part because of their ability to...
MaxCyte joins the Alliance for mRNA Medicines (AMM) as a founding member
MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, today announced that it has joined the Alliance...
A bi-directional iterative approach to Android automated testing
With the benefits of reducing time-cost and human efforts, automated testing has been widely used for quality assurance of mobile applications (apps). However, in complex interactive activities, manual testing can achieve higher coverage. However,...
AstraZeneca Taps Biopharma Expertise to Boost Renewable Energy Efforts
By Gail Dutton
Renewable energy production and biopharmaceutical manufacturing, at first glance, lack nexus. AstraZeneca, however, saw the connection and is using its expertise in biomanufacturing to help its partner, Vanguard Renewables, extract energy more...
Breakthrough study: inhibiting USP30 gene offers hope in treating Parkinson’s disease
In a recent study published in Nature Communications, researchers investigated whether USP30 inhibition can serve as a disease-modifying therapy for Parkinson's disease (PD) by enhancing mitophagy and reducing α-synuclein (αSyn) pathology. Study: Knockout or inhibition...
The role of iron in blindness caused by ocular toxoplasmosis
Researchers from Nagoya University Graduate School of Medicine have identified the role of iron in ocular toxoplasmosis (OT), a form of toxoplasmosis that causes blindness. They found reduced iron concentration in the clear gel...
New approach to CAR T cell therapy may extend treatment effectiveness
CAR T cell therapy, a powerful type of immunotherapy, has begun to revolutionize cancer treatment. Pioneered at Memorial Sloan Kettering Cancer Center (MSK), the therapy involves engineering a patient's T cells so they recognize...
Lonza Launches New Cell Line and MilliporeSigma Introduces Digital Reference Materials Platform
Lonza officials say the company’s new GS Effex® cell line is designed to help biotech firms develop more sophisticated therapeutic antibodies. Combined with good cell growth and the ability to produce therapeutic antibodies with increased...
